HomeOur People

Our people.

Executive Leadership Team.

Tom Watson

Chief Executive Officer

Carl Hvass

Chief Financial Officer

Ian Fraser

Chief Operating Officer

Andreia de Melo Cabral

Chief People Officer

Roseanne Day

Chief Legal Officer

John Efthimiou

Chief Medical Officer

Senior Leadership Team.

Jen Otto

Executive Vice President, Clinical Development

Tom White

Executive Vice President, Clinical Trial Supply

Ellie Matthews

Executive Vice President, Early Access Programs

Behrad Behmardi

Executive Vice President, Information Technology

Caroline Stanton

Senior Vice President, Quality Assurance

Graham Sidorowicz

Executive Vice President, Commercial

Katie Clayton

Vice President, Marketing

Cath Lawrence

Vice President, Rare Disease

Jo Elsden

Vice President, Pharmacovigilance

How can we support you?

Our dedicated teams of experts are on hand to help should you require any additional resource or further information about our services.

COVID-19 Guidance & Measures

A statement from the Bionical Emas Group on guidance & measures regarding COVID-19 - read here

In relation to staff and visitor safety, we have full risk assessments in place for all of our workplaces. These risk assessments are revisited and updated regularly, to reflect changing risks, knowledge and circumstances, and to reflect evolving Government guidance. We have not placed the risk assessments here on the website as they would become out of date too quickly. However, you are welcome to email info@bionical-emas.com to request access to our most up to date risk assessments applicable to your needs. Please note that all our staff are notified of all applicable risk assessments and updates, along with ‘quick guides’ automatically via our e-learning system.